Celiac Disease: Latest Treatment Options
Celiac disease, an autoimmune disorder triggered by gluten ingestion, leads to inflammation and damage in the small intestine. Recent advancements in treatment options are significantly improving disease management and patient quality of life. The cornerstone of current treatment remains a strict, lifelong gluten-free diet, which effectively alleviates symptoms and promotes intestinal healing. However, new therapeutic approaches are emerging to complement dietary management. Enzyme therapies, such as glutenase supplements, are being developed to break down gluten in the digestive tract, potentially reducing the need for complete dietary avoidance. Additionally, novel medications, including immune-modulating agents and compounds that block gluten's toxic effects, are undergoing clinical trials. These treatments aim to reduce immune response or protect the intestinal lining from gluten damage. Furthermore, research into vaccine development, which seeks to desensitize the immune system to gluten, is ongoing. These latest treatment options represent a promising shift towards more effective management and potential long-term solutions for celiac disease.
Related Conference of Celiac Disease: Latest Treatment Options
26th International Conference on Gastroenterology and Hepatology
25th International Conference on Gastroenterology and Digestive Disorders
27th International Conference on Gastroenterology and Hepatology
Celiac Disease: Latest Treatment Options Conference Speakers
Recommended Sessions
- Advances in Gastrointestinal Oncology
- Advances in GERD Treatment
- Alcoholic Liver Disease: Emerging Treatments
- Barrett’s Esophagus: Current Therapeutics
- Celiac Disease: Latest Treatment Options
- Emerging Therapies for Crohn's
- Esophageal Disorders: Current Treatments
- Gastrointestinal Stromal Tumors: Novel Therapies
- Hepatic Encephalopathy: Modern Management Strategies
- Hepatitis C Therapeutics
- Hepatocellular Carcinoma: Latest Approaches
- Innovations in IBD Management
- Liver Cirrhosis: New Therapies
- Microbiome and Gastrointestinal Health
- NAFLD and NASH Treatments
- New Approaches to Peptic Ulcer Disease
- Pancreatitis: Modern Therapeutic Strategies
- Therapeutics for Biliary Diseases
- Ulcerative Colitis: Innovative Treatments
- Viral Hepatitis: New Treatment Paradigms
Related Journals
Are you interested in
- Advances in Medical Imaging - Gastrosummit 2027 (France)
- Celiac Disease - Gastrosummit 2027 (France)
- Colorectal Diseases - Gastrosummit 2027 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - Gastrosummit 2027 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastrointestinal Bleeding - Gastrosummit 2027 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Pharmacology - Gastrosummit 2027 (France)
- Gastrointestinal Surgery - Gastrosummit 2027 (France)
- Geriatric Gastroenterology - Gastrosummit 2027 (France)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2027 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastrosummit 2027 (France)
- Liver Transplantation - Gastrosummit 2027 (France)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition in Digestive Health - Gastrosummit 2027 (France)
- Pancreatic Diseases - Gastrosummit 2027 (France)
- Pancreaticobiliary Disorders - Gastrosummit 2027 (France)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology - Gastrosummit 2027 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Precision Medicine in Digestive Diseases - Gastrosummit 2027 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Viral Hepatitis - Gastrosummit 2027 (France)
